glp-1 for chronic pain drugs calm inflammation beyond diabetes and weight loss GLP-1 Drugs: For Multiple Chronic

Semaglutide, a GLP-1RA, mitigates seizure severity and cognitive impairment through the inhibition of the lipopolysaccharide (LPS)- and nigericin-induced NLRP3 inflammasome pathway, reducing lactate dehydrogenase (LDH) release by microglial cells [53]

In addition, many small molecule GLP-1R agonists have been reported recently [4]

The idea is to get immediate results while the long-term medication builds up in the system

Oral F.n translocate to the intestine by resisting the acidic environment at pH 1.5 owing to the presence of erucic acid in its cell membrane, which is regulated by FnFabM, increasing its colonization efficiency in the stomach and jejunum of mice (Li et al., 2025)

NaBPC157 (1.50 g or 15.0 ng/kg b.w., i.p.) was applied 15 minutes before or alternatively 15 minutes after each MPTP administration